icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections
Virtual
February 12-16, 2022
Back grey_arrow_rt.gif
 
 
 
Lenacapavir as part of a Combination Regimen in Treatment-Naïve People with HIV: Week 54 Results
 
 
  CROI 2022 Feb 16
 
Samir K. Gupta,1 James Sims,2 Cynthia Brinson,3 Frederick A. Cruickshank,4 Godson Oguchi,5 Javier Morales,6 Theo Hodge,7 Craig Dietz,8 Angela S. Liu,9 Laurie VanderVeen,9 Hadas Dvory-Sobol,9 Martin S. Rhee,9 Jared M. Baeten,9 Ellen Koenig10 1Indiana University School of Medicine, Indianapolis, IN, USA; 2St. Hope Foundation, Bellaire, TX, USA; 3Central Texas Clinical Research, Austin, TX, USA; 4Rosedale Infectious Diseases, Huntersville, NC, USA; 5Midland Florida Clinical Research Center, LLC, Deland, FL, USA; 6Clinical Research Puerto Rico Inc, San Juan, Puerto Rico, USA; 7Washington Health Institute, Washington DC, USA; 8Kansas City Care Health Center, Kansas City, MO, USA; 9Gilead Sciences Inc., Foster City, CA, USA; 10Instituto Dominicano de Estudios Virológicos, Santo Domingo, Dominican Republic

0216221

0216222

0216223

0216224

0216225

0216226

0216227

0216228